Hormone therapy is still the most effective treatment for hot flashes, but plenty of women can’t take it or would rather not. Several non-hormonal options help, including two recent drugs built specifically for this.
First, is hormone therapy really off the table?
Worth a pause here, because a lot of women rule out hormones based on old scare headlines, and for many of them the risks are smaller than they were told (here’s the actual breakdown). The genuine reasons to avoid systemic hormones include a history of breast cancer, blood clots, a recent stroke or heart attack, or active liver disease.1 A history of endometrial cancer is more case-specific: early-stage disease may be handled differently than advanced or recurrent disease, so that decision belongs with your gynecologist or oncology team rather than a generic menopause clinic. If hormones aren’t a good fit, or you’ve weighed it and would rather not use them, the rest of this article is for you.
The two new drugs
These are the recent developments. Both block a brain pathway (the NK3 receptor) that helps trigger hot flashes, so they work without any hormones. Fezolinetant (Veozah, approved 2023) cuts moderate-to-severe hot flashes by about two to three a day more than placebo and starts working within a week,2 but it carries a boxed warning for liver injury and needs blood tests at baseline and over the first several months.3 Elinzanetant (Lynkuet, approved late 2025) works about as well, also meaningfully improves sleep,4 and needs lighter liver monitoring.5 They’re effective and targeted. The catches are cost, especially if insurance doesn’t cover them, and that they’ve only been out for about a year, so safety data is still limited.6
The older options: antidepressants, gabapentin, oxybutynin
Cheaper and well understood, if more modest. Low-dose paroxetine is the one antidepressant actually FDA-approved for hot flashes; others like escitalopram and venlafaxine work similarly off-label, cutting flashes by roughly 10 to 25 percent more than placebo, and they’re inexpensive generics.3 That makes one of them a reasonable first try, especially if your mood or sleep is also struggling. Gabapentin helps too, particularly with night-time flashes, at the cost of some drowsiness.3 Oxybutynin actually has one of the larger effects among the older drugs, but it’s an anticholinergic, so it’s generally avoided over age 65 because of the link to cognitive decline.3 None of these match standard-dose estrogen, but for a lot of women they take the edge off enough to matter.
Treatment table: what helps, and what you give up
| Option | Expected role | Main tradeoff |
|---|---|---|
| Fezolinetant | Targeted non-hormonal drug for moderate-to-severe flashes | Liver warning and monitoring |
| Elinzanetant | Targeted non-hormonal option that may also help sleep | Newer drug, so long-term data are still limited |
| SSRI or SNRI | Inexpensive first-line generic option | Modest effect and usual antidepressant side effects |
| Gabapentin | Especially useful when night sweats disrupt sleep | Drowsiness |
| Oxybutynin | Can work well for flashes | Anticholinergic burden, especially over age 65 |
| CBT | Reduces bother, sleep disruption, and distress | Does not usually cut flash frequency |
| Supplements and black cohosh | Popular, but not recommended by NAMS | Placebo-level evidence for flash frequency |
What about the natural stuff? And CBT?
Here’s where to save your money. The main menopause society (NAMS) reviewed the evidence in 2023 and does not recommend supplements, black cohosh, soy or other phytoestrogens, acupuncture, paced breathing, yoga, mindfulness, or cooling gadgets for hot flashes; in good trials they don’t beat placebo for flash frequency.7 The one non-drug approach with solid evidence is cognitive behavioral therapy (CBT). It doesn’t make hot flashes happen less often, but it reliably reduces how much they bother you and improves sleep and mood, and the benefit lasts.8 It can be useful on its own or alongside a drug.
Where non-hormonal treatments fall short
Two things to keep in mind. First, the absolute effect of even the good non-hormonal drugs is modest: roughly one to three fewer hot flashes a day, against a baseline that’s often seven to fifteen. Some analyses argue that falls short of what women would actually call a meaningful difference.9 Second, hot-flash trials have a huge placebo response, around 50 percent,3 so any “this cut my flashes by 60 percent” claim, including for supplements, is mostly placebo plus the natural ebb of symptoms over time. Judge a treatment by how far it beats placebo, not by the headline percentage.
Choose the least burdensome option that actually helps
First, make sure hormones are actually off the table, because they’re still the most effective option and often safer than assumed; if you’re not sure, start with the perimenopause overview. If hormones are truly out: when cost and insurance coverage allow, the new NK3 blockers (especially elinzanetant, which also helps sleep) are the most targeted non-hormonal drugs. If insurance doesn’t cover them, a low-dose antidepressant like venlafaxine or paroxetine is a sensible first step, particularly if mood or sleep are also off. Add CBT, which helps the bother and the sleep no matter what else you’re doing. Skip the supplements and the black cohosh. The evidence just isn’t there.